ChIP sequencing market seen reaching $29.02 billion by 2030
The chromatin immunoprecipitation sequencing market is projected to grow from $15.48 billion in 2025 to $17.42 billion in 2026, with the market expected to reach $29.02 billion by 2030. Growth is being driven by epigenomics investment, AI-based genomic analytics and demand from cancer research, especially prostate cancer studies.
Why it matters: - ChIP sequencing is becoming more important for genome-wide protein-DNA interaction mapping, a core tool for studying gene regulation, epigenetics and disease mechanisms. - The market’s expansion signals rising demand for advanced research tools that support precision medicine, multi-omics integration and bioinformatics workflows. - Prostate cancer research is adding urgency, since ChIP-seq helps scientists better understand tumor biology and identify treatment targets.
What happened: - The Business Research Company released its Chromatin Immunoprecipitation (ChIP) Sequencing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the ChIP sequencing market will rise from $15.48 billion in 2025 to $17.42 billion in 2026. - The report projects the market will reach $29.02 billion by 2030. - The forecast implies a 12.5% CAGR from 2025 to 2026 and a 13.6% CAGR through 2030.
The details: - Market growth is linked to increased investment in epigenomics research. - Adoption of AI-driven genomic analytics is supporting demand. - Precision medicine is another major growth driver. - The market is also benefiting from multi-omics data integration and cloud-based bioinformatics tools. - Key trends include wider use of genome-wide protein-DNA interaction mapping, high-throughput sequencing platforms and bioinformatics pipelines for regulatory genomics. - The report includes geographic coverage across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report says North America’s lead is supported by research infrastructure, funding and pharmaceutical development. - The report says Asia-Pacific growth will be supported by academic investment, biotech expansion and healthcare research initiatives. - The company is offering a free sample of the report here.
Between the lines: - The forecast suggests ChIP sequencing is moving from a specialized research tool to a broader platform tied to faster genomic analysis and translational research. - Cancer research remains a practical demand driver, with prostate cancer highlighted as one example of a disease area that depends on deeper molecular profiling. - The report’s focus on AI, cloud tools and bioinformatics points to a market where software and data analysis matter as much as sequencing itself.
What's next: - The report expects continued market expansion through 2030 as research spending and genomics adoption rise. - More demand is likely from institutions building integrated omics and regulatory genomics capabilities. - The company says its 2026 reports include updated market intelligence, TAM analysis, company scoring tools, forecasting dashboards and trend analysis.
The bottom line: - ChIP sequencing is on a strong growth path, with research funding, AI-enabled analytics and cancer studies driving a market projected to nearly double by 2030.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Middle East Business Channel
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.